Showing 1 - 4 results of 4 for search 'SiCheng Wu' Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Author
  • SiCheng Wu
Showing 1 - 4 results of 4 for search 'SiCheng Wu', query time: 0.04s Refine Results
  1. 1
    Unsupervised discovery of thin-film photovoltaic materials from unlabeled data

    Unsupervised discovery of thin-film photovoltaic materials from unlabeled data by Zhilong Wang, Junfei Cai, Qingxun Wang, SiCheng Wu, Jinjin Li

    Published 2021-08-01
    Get full text
    Article
  2. 2
    Clinical and Oculomotor Correlates With Freezing of Gait in a Chinese Cohort of Parkinson’s Disease Patients

    Clinical and Oculomotor Correlates With Freezing of Gait in a Chinese Cohort of Parkinson’s Disease Patients by Li Wu, Qin Wang, Lei Zhao, Chun-Yan Jiang, Qian Xu, Si-Cheng Wu, You-Rong Dong, Qing He, Wei Chen, Jian-Ren Liu

    Published 2020-07-01
    Get full text
    Article
  3. 3
    Clinical and cVEMP Evaluation Predict Short-Term Residual Dizziness After Successful Repositioning in Benign Paroxysmal Positional Vertigo

    Clinical and cVEMP Evaluation Predict Short-Term Residual Dizziness After Successful Repositioning in Benign Paroxysmal Positional Vertigo by Chun-Yan Jiang, Chun-Yan Jiang, Jing Wu, Liang Shu, Xu-Hong Sun, Hui Pan, Qian Xu, Si-Cheng Wu, Jian-Ren Liu, Yun Li, Yun Li, Wei Chen

    Published 2022-05-01
    Get full text
    Article
  4. 4
    A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma

    A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinoma by Wu-tong Ju, Rong-hui Xia, Dong-wang Zhu, Sheng-jin Dou, Guo-pei Zhu, Min-jun Dong, Li-zhen Wang, Qi Sun, Tong-chao Zhao, Zhi-hang Zhou, Si-yuan Liang, Ying-ying Huang, Yong Tang, Si-cheng Wu, Jing Xia, Shi-qing Chen, Yue-zong Bai, Jiang Li, Qi Zhu, Lai-ping Zhong

    Published 2022-09-01
    Get full text
    Article

Search Tools:

  • RSS Feed
  • Email Search

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs